Skip to main content

Animations

MJFF Publications

2861 - 2870 of 6420 Results
Title
Year
  • Year
  • 2019
  • 2019
  • 2019
  • 2019
  • 2019
  • 2019
  • 2019
  • 2019
  • 2019
  • 2019
  • Summary Details
    OPEN
    Title: Cholinergic system changes of falls and freezing of gait in Parkinson's disease
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/ana.25430
    Citation Count: 155
  • Summary Details
    OPEN
    Title: Comparative study of PROMISⓇ self-efficacy for managing chronic conditions across chronic neurologic disorders
    Journal Name: Quality of Life Research
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s11136-019-02164-2
    Citation Count: 21
  • Summary Details
    OPEN
    Title: Nucleic Acid–Based Therapeutics for Parkinson's Disease
    Journal Name: Neurotherapeutics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s13311-019-00714-7
    Citation Count: 52
  • Summary Details
    OPEN
    Title: The Parkinson’s disease-linked Leucine-rich repeat kinase 2 (LRRK2) is required for insulin-stimulated translocation of GLUT4
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-019-40808-y
    Citation Count: 26
  • Summary Details
    OPEN
    Title: Defective homologous recombination DNA repair as therapeutic target in advanced chordoma
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-019-09633-9
    Citation Count: 83
  • Summary Details
    OPEN
    Title: Prioritizing Parkinson’s disease genes using population-scale transcriptomic data
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-019-08912-9
    Citation Count: 159
  • Summary Details
    OPEN
    Title: Brain tyrosinase overexpression implicates age-dependent neuromelanin production in Parkinson’s disease pathogenesis
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-019-08858-y
    Citation Count: 313
  • Summary Details
    OPEN
    Title: The PINK1 kinase-driven ubiquitin ligase Parkin promotes mitochondrial protein import through the presequence pathway in living cells
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-019-47352-9
    Citation Count: 53
  • Summary Details
    OPEN
    Title: Mutations that prevent caspase cleavage of RIPK1 cause autoinflammatory disease
    Journal Name: Nature
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41586-019-1828-5
    Citation Count: 284
  • Summary Details
    OPEN
    Title: Levels of glutamatergic neurometabolites in patients with severe treatment-resistant schizophrenia: a proton magnetic resonance spectroscopy study
    Journal Name: Neuropsychopharmacology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41386-019-0589-z
    Citation Count: 57
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.